Literature DB >> 10595722

Determination of norgestimate and its metabolites in human serum using high-performance liquid chromatography with tandem mass spectrometric detection.

F A Wong1, R W Edom, M Duda, J P Tischio, M Huang, S Juzwin, G Tegegne.   

Abstract

A rapid and reliable analytical method is described for the simultaneous determination of a synthetic progestin norgestimate (NGM), and its metabolites, 17-deacetylnorgestimate (17-DA-NGM), 3-ketonorgestimate (3-keto-NGM) and norgestrel (NGL) in human serum using reversed phase high-performance liquid chromatography (HPLC) with tandem mass spectrometric (MS-MS) detection. The assay was linear over the concentration ranges of 0.1-5.0 ng/ml for 17-DA-NGM and NGL and 0.5-5.0 ng/ml for NGM and 3-keto-NGM. The inter-assay reproducibility was consistently less than 10%. The overall recovery of the analytes ranged from 72 to 92%. Serum profiles following oral administration of norgestimate to female volunteers are presented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595722     DOI: 10.1016/s0378-4347(99)00353-9

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  3 in total

1.  Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites.

Authors:  Larry S Abrams; Donna M Skee; Jaya Natarajan; Frankie A Wong; Gary D Anderson
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

2.  Effect of raltegravir on estradiol and norgestimate plasma pharmacokinetics following oral contraceptive administration in healthy women.

Authors:  Matt S Anderson; William D Hanley; Allison R Moreau; Bo Jin; Frederick A Bieberdorf; James T Kost; Larissa A Wenning; Julie A Stone; John A Wagner; Marian Iwamoto
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

3.  Quantification of 17-desacetyl norgestimate in human plasma by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and its application to bioequivalence study.

Authors:  Ashish Saxena; Arun Kumar Gupta; V Praveen Kumar; M Sundaramoorthi Nainar; Manoj Bob; Ravisekhar Kasibhatta
Journal:  J Pharm Anal       Date:  2014-09-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.